Images
![Rivastigmine transdermal (Rivastigmine transdermal [ riv-a-stig-meen ])-SANDOZ 620-4.5 mg-Red-Capsule-shape](https://cdn.themeditary.com/vimedia/h200/2023/08/15/rivastigmine-rivastigmine-oral-ri-va-stig-meen-sandoz-620-4-5-mg-red-capsule-shape-54578311-16892.webp "SANDOZ 620 Pill - red capsule-shape, 18mm")
![Rivastigmine transdermal (Rivastigmine transdermal [ riv-a-stig-meen ])-SANDOZ 620-4.5 mg-Red-Capsule-shape](https://cdn.themeditary.com/vimedia/h200/2023/08/15/rivastigmine-rivastigmine-oral-ri-va-stig-meen-sandoz-620-4-5-mg-red-capsule-shape-54578311-16893.webp "SANDOZ 620 Pill - red capsule-shape, 18mm")
Rivastigmine transdermal |
|
| Generic Name: | rivastigmine transdermal [ riv-a-stig-meen ] |
| Imprint: | SANDOZ 620 |
| Strength: | 4.5 mg |
| Color: | Red |
| Size: | 18.00 mm |
| Shape: | Capsule-shape |
| Availability: | Prescription only |
| Drug Class: | Cholinesterase inhibitors |
| Pregnancy Category: | B - No proven risk in humans |
| CSA Schedule: | Not a controlled drug |
| Labeler / Supplier: | N/A |
| National Drug Code (NDC): | 00781-2616 (Discontinued) |
| Inactive Ingredients: | Gelatin, Hypromelloses, Magnesium stearate, Microcrystalline cellulose, Ferric oxide red, Silicon dioxide, Titanium dioxide, Ferric oxide yellow, |
